DDX5 and chronic myelogenous leukemia, BCR-ABL1 positive: In future studies, we need to demonstrate the importance of DDX5 in CML pathogenesis using other BCR-ABL-positive leukemic cell lines such as KYO1, LAMA84, EM2, EM3, BV173, AR230, KU812, and KCL22.